Description

Levothyroxine Tablet

Levothyroxine Sodium Tablets USP / BP / IP (25 mcg to 200 mcg)

High-Precision Synthetic Thyroid Hormone ($T_{4}$) Replacement

Healthy Life Pharma Private Limited, together with our specialized global export and marketing division Healthy Inc, is a leading Indian manufacturer, CDMO services provider, and wholesale exporter of advanced endocrinology, metabolic health, and hormone replacement therapeutics. We manufacture an internationally standardized, high-precision spectrum of Levothyroxine Sodium Tablets inside our state-of-the-art, WHO–GMP certified, climate-controlled hormone manufacturing blocks.

As the absolute global gold standard for the life-long management of thyroid deficiency states, this essential public health commodity represents a massive-volume strategic asset for national health ministry tenders, state insurance procurement pipelines, retail pharmacy distribution chains, and digital B2B marketplaces across the CIS region, Africa, LATAM, and South-East Asia.

Product Overview

This formulation operates as a “Synthetic Synthetic Endogenous Isoform Prohormone.” It ensures systemic metabolic stabilization by precisely replicating the human body’s natural thyroid secretions to regulate cellular energy metabolism, protein synthesis, and systemic enzyme activity.

• Mechanism 1 (Peripheral Deiodination Transformation): Levothyroxine ($T_{4}$) is a synthetic form of the natural hormone secreted by the human thyroid gland. Once absorbed into the bloodstream, it is physically transported to peripheral tissues where it is chemically deiodinated by cellular enzymes into its active metabolite, Liothyronine ($T_{3}$).

• Mechanism 2 (Nuclear Transcription Activation): The active $T_{3}$ hormone physically crosses cell boundaries and enters the nucleus to bind with high affinity to specific nuclear thyroid hormone receptors.

• Mechanism 3 (Metabolic Rate Optimization): This metabolic binding triggers DNA transcription, chemically increasing the synthesis of critical structural and functional enzymes. The physical result is an immediate optimization of the body’s Basal Metabolic Rate (BMR), a boost in mitochondrial oxidative phosphorylation, an acceleration of carbohydrate and lipid metabolism, and a normalization of cardiovascular contractility.

Product Composition & Comprehensive Portfolio Range

Because thyroid replacement demands hyper-specific, patient-tailored titrations, we manufacture the entire internationally recognized microgram ($\mu\text{g}$) matrix.

Technical & Logistics Specifications

• HS Code: 3004.39.12 (Medicaments containing hormones / Levothyroxine Sodium or Thyroid derivatives) or 3004.90.99 (General Category)

• CAS Number: 25416-65-3 (Levothyroxine Sodium Monohydrate) / 51-48-9 (Levothyroxine Base)

• Dosage Form: Oral Solid Tablet (Engineered with distinct compendial visual color-coding variations to physically prevent strength mixing at pharmacies)

• Packaging Configurations:

  • Blister Packs: 10 / 14 / 28 Tablets per Strip packed exclusively in high-barrier Alu-Alu (Cold-Form Foil) or thick Opaque PVC/PVDC matrix strips.

  • Institutional Dispensing: Bulk packs of 100 / 500 / 1000 Tablets per induction-sealed HDPE Bottle featuring custom-integrated internal silica desiccant caps. Levothyroxine is an exceptionally fragile molecule that degrades rapidly when exposed to moisture and light; our premium tropicalized packaging guarantees a stable 36-month shelf life in hot, humid Zone IVb export environments.

NTI Microgram Manufacturing Engineering & Quality Attributes

                 [ MICRONIZED LEVOTHYROXINE API ]
                                │ (Particle size D90 < 5 micrometers)
                                ▼
           [ MULTI-STAGE GEOMETRIC SOLID BLENDING SYSTEM ]
                                │ (Layered carrier matrix execution)
                                ▼
            [ CONTINUOUS INDUSTRIAL CLIMATE ISO-BLOCK ]
                                │ (RH strictly maintained below 25%)
         ┌──────────────────────┴──────────────────────┐
         ▼                                             ▼
 [ FLUSH EXTRA-LOW TOLERANCE ]             [ SYSTEMIC BIOEQUIVALENCE ]
 Microgram Content Uniformity (95-105%)    Flawless NTI In-Vitro Dissolution

• Advanced Geometric Micro-Blending Suites: Levothyroxine is a Narrow Therapeutic Index (NTI) drug processed at profound micro-doses (e.g., 25 micrograms constitutes a tiny fraction of a percent of a 100 mg tablet core). To completely eliminate segregation defects, we utilize Micronized API ($D_{90} < 5\,\mu\text{m}$) and run it through a multi-stage, closed geometric layering sequence using specialized fluid diluents, physically guaranteeing a content uniformity score between 95.0% and 105.0%.

• Continuous Hydrolytic Environmental Shielding: Levothyroxine molecules easily undergo premature de-iodination and molecular cleavage if exposed to moisture during manufacturing. We isolate our entire automated compression lines within Specialized Negative-Pressure Cleanroom Suites with relative humidity strictly held below 25% RH and temperature regulated at 20°C.

• Automated In-Vitro Bioavailability Profiling: Every single production block physically undergoes automated multi-pH dissolution profiling, chemically validating that our generic tablets match the exact kinetic release curves of global innovator benchmarks (such as Synthroid / Euthyrox).

Primary Indications

• Endocrinology: Lifelong, comprehensive replacement therapy in congenital or acquired Primary, Secondary, and Tertiary Hypothyroidism (including Myxedema coma support).

• Thyroid Oncology Support: Suppression of Thyroid Stimulating Hormone (TSH) secretion in the medical management of thyrotropin-dependent well-differentiated thyroid carcinoma, and management of chronic euthyroid goiters.

Usage Instructions

• The Morning Fasting Mandate: Take the tablet orally once daily in the morning on an empty stomach, at least 30 to 60 minutes before breakfast, with a full glass of water. Administering the drug in a fasting state is physically critical, as dietary calcium, coffee, fibers, and iron can chemically chelate with the hormone matrix, dropping systemic absorption by up to 30%.

• The Single-Brand Compliance Directive: Due to its narrow therapeutic index nature, patients stabilized on a specific batch profile should maintain consistent brand therapy. Advise clinical and pharmacy networks to prevent arbitrary switching between generic suppliers without measuring steady-state serum TSH levels.

• Delayed Evaluation Window: Levothyroxine has a long plasma elimination half-life of approximately 6 to 7 days. Steady-state therapeutic evaluations via blood draws must only occur 6 to 8 weeks following initialization or dose modifications.

Safety Warning: HIGH-PRECISION NARROW THERAPEUTIC INDEX HORMONE. For Endocrinologist and Specialist Physician Supervision Only. The Cardiovascular Overload Warning: May chemically accelerate heart rate and myocardial oxygen demand; execute extreme physical caution and initiate at ultra-low doses (12.5 mcg to 25 mcg) in elderly profiles or patients presenting with severe underlying Coronary Artery Disease ($CAD$). Not For Weight Loss Control: Absolutely contraindicated for use as a primary chemical management tool for obesity or weight loss; high doses can induce life-threatening thyrotoxicosis and cardiac collapse. Contraindications: Absolute contraindications in patients presenting with uncorrected adrenal insufficiency (acute adrenal crisis risk), acute myocardial infarction, thyrotoxicosis, or known hypersensitivity to levothyroxine tablet matrices.

Global CDMO Services & Wholesale Tender Logistics

Healthy Life Pharma Private Limited and Healthy Inc provide comprehensive, internationally validated Third-Party Contract Manufacturing (CDMO Services) and bulk private-label export supply for the entire Levothyroxine Sodium dosage matrix. Operating under strict hormone-containment protocols, we prepare all mandatory cross-border documentation (WHO-GMP Certificate, Certificates of Pharmaceutical Product – COPP, Certificates of Analysis – COA, Zone IVb Stability Testing Data Packs, and Complete CTD Format Dossier sets) for seamless customs entry and rapid national registration.

Commercial & Bulk Procurement Inquiries:

• Corporate Head Office: Mumbai, Maharashtra, India

• Primary Manufacturing Base: Boisar, Maharashtra, India

• WhatsApp / Direct Regulatory Helpline: +91 7710003340

• Endocrine Registry Email: info@healthyinc.co.in